| Year |
Citation |
Score |
| 2024 |
Gagan S, Khapuinamai A, Kapoor D, Sharma P, Yadavalli T, Joseph J, Shukla D, Bagga B. Exploring Heparanase Levels in Tears: Insights From Herpes Simplex Virus-1 Keratitis Patients and Animal Studies. Investigative Ophthalmology & Visual Science. 65: 7. PMID 38466284 DOI: 10.1167/iovs.65.3.7 |
0.448 |
|
| 2024 |
Naqvi RA, Valverde A, Yadavalli T, Bobat FI, Capistrano KJ, Shukla D, Naqvi AR. Viral MicroRNAs in Herpes Simplex Virus 1 Pathobiology. Current Pharmaceutical Design. PMID 38347772 DOI: 10.2174/0113816128286469240129100313 |
0.331 |
|
| 2023 |
Bhattacharya I, Volety I, Shukla D. OPTN-TBK1 axis and a role for PLK1 in HSV-1 infection. Mbio. 14: e0271523. PMID 38019030 DOI: 10.1128/mbio.02715-23 |
0.563 |
|
| 2023 |
Yadavalli T, Patil C, Sharma P, Volety I, Borase H, Kapoor D, Shukla D. Unique Attributes of Guinea Pigs as New Models to Study Ocular Herpes Pathophysiology and Recurrence. Investigative Ophthalmology & Visual Science. 64: 41. PMID 38015175 DOI: 10.1167/iovs.64.14.41 |
0.443 |
|
| 2023 |
Borase H, Shukla D. The Interplay of Genital Herpes with Cellular Processes: A Pathogenesis and Therapeutic Perspective. Viruses. 15. PMID 38005873 DOI: 10.3390/v15112195 |
0.394 |
|
| 2023 |
Sutar Y, Singh SK, Dhoble S, Mali J, Adams J, Yadavalli T, Date AA, Shukla D. Oral Self-Nanoemulsifying System Containing Ionic Liquid of BX795 Is Effective against Genital HSV-2 Infection in Mice. Acs Infectious Diseases. PMID 37807721 DOI: 10.1021/acsinfecdis.3c00212 |
0.329 |
|
| 2023 |
Chopra P, Yadavalli T, Palmieri F, Jongkees SAK, Unione L, Shukla D, Boons GJ. Synthetic Heparanase Inhibitors Can Prevent Herpes Simplex Viral Spread. Angewandte Chemie (International Ed. in English). e202309838. PMID 37555536 DOI: 10.1002/anie.202309838 |
0.568 |
|
| 2023 |
Yin XT, Hartman A, Sirajuddin N, Shukla D, Leger AS, Keadle TL, Stuart PM. UV-B induced HSV-1 reactivation leads to infectious virus in the corneas of virtually all latently infected mice and requires an intact STING to develop herpetic stromal keratitis. Research Square. PMID 37502845 DOI: 10.21203/rs.3.rs-3097720/v1 |
0.35 |
|
| 2023 |
Suryawanshi RK, Patil CD, Agelidis A, Koganti R, Yadavalli T, Ames JM, Borase H, Shukla D. Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction. Science Advances. 9: eadf3977. PMID 37115924 DOI: 10.1126/sciadv.adf3977 |
0.54 |
|
| 2023 |
Kapoor D, Shukla D. Neutrophil Extracellular Traps and Their Possible Implications in Ocular Herpes Infection. Pathogens (Basel, Switzerland). 12. PMID 36839481 DOI: 10.3390/pathogens12020209 |
0.476 |
|
| 2023 |
Elste J, Chan A, Patil C, Tripathi V, Shadrack DM, Jaishankar D, Hawkey A, Mungerson MS, Shukla D, Tiwari V. Archaic connectivity between the sulfated heparan sulfate and the herpesviruses - An evolutionary potential for cross-species interactions. Computational and Structural Biotechnology Journal. 21: 1030-1040. PMID 36733705 DOI: 10.1016/j.csbj.2023.01.005 |
0.36 |
|
| 2022 |
Suryawanshi RK, Patil CD, Wu D, Panda PK, Singh SK, Volety I, Ahuja R, Mishra YK, Shukla D. Putative targeting by BX795 causes decrease in protein kinase C protein levels and inhibition of HSV1 infection. Antiviral Research. 208: 105454. PMID 36334637 DOI: 10.1016/j.antiviral.2022.105454 |
0.429 |
|
| 2022 |
Sharma P, Kapoor D, Shukla D. Role of Heparanase and Syndecan-1 in HSV-1 Release from Infected Cells. Viruses. 14. PMID 36298711 DOI: 10.3390/v14102156 |
0.581 |
|
| 2022 |
Patil CD, Suryawanshi RK, Kapoor D, Shukla D. Postinfection Metabolic Reprogramming of the Murine Trigeminal Ganglion Limits Herpes Simplex Virus-1 Replication. Mbio. e0219422. PMID 36043789 DOI: 10.1128/mbio.02194-22 |
0.436 |
|
| 2022 |
Yadavalli T, Sharma P, Wu D, Kapoor D, Shukla D. CREB3 Plays an Important Role in HPSE-Facilitated HSV-1 Release in Human Corneal Epithelial Cells. Viruses. 14. PMID 35746643 DOI: 10.3390/v14061171 |
0.57 |
|
| 2022 |
Bhattacharya I, Yadavalli T, Wu D, Shukla D. Plasma Membrane-Derived Liposomes Exhibit Robust Antiviral Activity against HSV-1. Viruses. 14. PMID 35458528 DOI: 10.3390/v14040799 |
0.448 |
|
| 2022 |
Grinage E, Shukla D. Optineurin in ocular herpes infection. Experimental Eye Research. 219: 109059. PMID 35390332 DOI: 10.1016/j.exer.2022.109059 |
0.555 |
|
| 2022 |
Iqbal A, Suryawanshi R, Yadavalli T, Volety I, Shukla D. Erratum to "BX795 demonstrates potent antiviral benefits against herpes simplex Virus-1 infection of human cell lines" [Antivir. Res. 80 (2020) 104814]. Antiviral Research. 200: 105293. PMID 35337670 DOI: 10.1016/j.antiviral.2022.105293 |
0.558 |
|
| 2022 |
Patil CD, Shukla D. OPTN (optineurin)-mediated selective autophagy prevents neurodegeneration due to herpesvirus infection. Autophagy. 1-2. PMID 35167411 DOI: 10.1080/15548627.2022.2037223 |
0.464 |
|
| 2021 |
Patil CD, Suryawanshi R, Ames J, Koganti R, Agelidis A, Kapoor D, Yadavalli T, Koujah L, Tseng HC, Shukla D. Intrinsic Antiviral Activity of Optineurin Prevents Hyperproliferation of a Primary Herpes Simplex Virus Type 2 Infection. Journal of Immunology (Baltimore, Md. : 1950). 208: 63-73. PMID 34880107 DOI: 10.4049/jimmunol.2100472 |
0.59 |
|
| 2021 |
Koujah L, Madavaraju K, Agelidis AM, Patil CD, Shukla D. Heparanase-Induced Activation of AKT Stabilizes β-Catenin and Modulates Wnt/β-Catenin Signaling during Herpes Simplex Virus 1 Infection. Mbio. 12: e0279221. PMID 34749529 DOI: 10.1128/mBio.02792-21 |
0.342 |
|
| 2021 |
Yadavalli T, Volety I, Shukla D. Aptamers in Virology-A Consolidated Review of the Most Recent Advancements in Diagnosis and Therapy. Pharmaceutics. 13. PMID 34683938 DOI: 10.3390/pharmaceutics13101646 |
0.377 |
|
| 2021 |
Suryawanshi RK, Patil CD, Agelidis A, Koganti R, Ames JM, Koujah L, Yadavalli T, Madavaraju K, Shantz LM, Shukla D. mTORC2 confers neuroprotection and potentiates immunity during virus infection. Nature Communications. 12: 6020. PMID 34650053 DOI: 10.1038/s41467-021-26260-5 |
0.508 |
|
| 2021 |
Yadavalli T, Volety I, Shukla D. Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals. Journal of Visualized Experiments : Jove. PMID 34605808 DOI: 10.3791/62195 |
0.484 |
|
| 2021 |
Karasneh GA, Kapoor D, Bellamkonda N, Patil CD, Shukla D. Protease, Growth Factor, and Heparanase-Mediated Syndecan-1 Shedding Leads to Enhanced HSV-1 Egress. Viruses. 13. PMID 34578329 DOI: 10.3390/v13091748 |
0.82 |
|
| 2021 |
Naqvi AR, Schwartz J, Brandini DA, Schaller S, Hussein H, Valverde A, Naqvi RA, Shukla D. COVID-19 and oral diseases: Assessing manifestations of a new pathogen in oral infections. International Reviews of Immunology. 1-15. PMID 34525891 DOI: 10.1080/08830185.2021.1967949 |
0.343 |
|
| 2021 |
Ames J, Yadavalli T, Suryawanshi R, Hopkins J, Agelidis A, Patil C, Fredericks B, Tseng H, Valyi-Nagy T, Shukla D. OPTN is a host intrinsic restriction factor against neuroinvasive HSV-1 infection. Nature Communications. 12: 5401. PMID 34518549 DOI: 10.1038/s41467-021-25642-z |
0.526 |
|
| 2021 |
Madavaraju K, Yadavalli T, Singh SK, Qatanani F, Shukla D. Prophylactic treatment with BX795 blocks activation of AKT and its downstream targets to protect vaginal keratinocytes and vaginal epithelium from HSV-2 infection. Antiviral Research. 105145. PMID 34303747 DOI: 10.1016/j.antiviral.2021.105145 |
0.506 |
|
| 2021 |
Suryawanshi RK, Patil CD, Koganti R, Singh SK, Ames JM, Shukla D. Heparan Sulfate Binding Cationic Peptides Restrict SARS-CoV-2 Entry. Pathogens (Basel, Switzerland). 10. PMID 34202835 DOI: 10.3390/pathogens10070803 |
0.307 |
|
| 2021 |
Tiwari V, Koganti R, Russell G, Sharma A, Shukla D. Role of Tunneling Nanotubes in Viral Infection, Neurodegenerative Disease, and Cancer. Frontiers in Immunology. 12: 680891. PMID 34194434 DOI: 10.3389/fimmu.2021.680891 |
0.479 |
|
| 2021 |
Koganti R, Memon A, Shukla D. Emerging Roles of Heparan Sulfate Proteoglycans in Viral Pathogenesis. Seminars in Thrombosis and Hemostasis. 47: 283-294. PMID 33851373 DOI: 10.1055/s-0041-1725068 |
0.585 |
|
| 2021 |
Koujah L, Allaham M, Patil CD, Ames JM, Suryawanshi RK, Yadavalli T, Agelidis A, Mun C, Surenkhuu B, Jain S, Shukla D. Entry receptor bias in evolutionarily distant HSV-1 clinical strains drives divergent ocular and nervous system pathologies. The Ocular Surface. PMID 33766740 DOI: 10.1016/j.jtos.2021.03.005 |
0.426 |
|
| 2021 |
Agelidis A, Turturice BA, Suryawanshi RK, Yadavalli T, Jaishankar D, Ames J, Hopkins J, Koujah L, Patil CD, Hadigal SR, Kyzar EJ, Campeau A, Wozniak JM, Gonzalez DJ, Vlodavsky I, ... ... Shukla D, et al. Disruption of innate defense responses by endoglycosidase HPSE promotes cell survival. Jci Insight. PMID 33621216 DOI: 10.1172/jci.insight.144255 |
0.475 |
|
| 2021 |
Koganti R, Yadavalli T, Naqvi RA, Shukla D, Naqvi AR. Pathobiology and treatment of viral keratitis. Experimental Eye Research. 205: 108483. PMID 33556334 DOI: 10.1016/j.exer.2021.108483 |
0.381 |
|
| 2021 |
Yadavalli T, Koganti R, Shukla D. Infection-Induced Porcine Ex Vivo Corneal Wound Model to Study the Efficacy of Herpes Simplex Virus-1 Entry and Replication Inhibitors. Methods in Molecular Biology (Clifton, N.J.). 2193: 183-196. PMID 32808270 DOI: 10.1007/978-1-0716-0845-6_18 |
0.621 |
|
| 2020 |
Madavaraju K, Koganti R, Volety I, Yadavalli T, Shukla D. Herpes Simplex Virus Cell Entry Mechanisms: An Update. Frontiers in Cellular and Infection Microbiology. 10: 617578. PMID 33537244 DOI: 10.3389/fcimb.2020.617578 |
0.567 |
|
| 2020 |
Suryawanshi RK, Koganti R, Agelidis A, Patil CD, Shukla D. Dysregulation of Cell Signaling by SARS-CoV-2. Trends in Microbiology. PMID 33451855 DOI: 10.1016/j.tim.2020.12.007 |
0.402 |
|
| 2020 |
Yadavalli T, Suryawanshi R, Koganti R, Hopkins J, Ames J, Koujah L, Iqbal A, Madavaraju K, Agelidis A, Shukla D. Standalone or combinatorial phenylbutyrate therapy shows excellent antiviral activity and mimics CREB3 silencing. Science Advances. 6. PMID 33277262 DOI: 10.1126/sciadv.abd9443 |
0.506 |
|
| 2020 |
Hopkins J, Yadavalli T, Suryawanshi R, Qatanani F, Volety I, Koganti R, Iqbal A, Shukla D. In Vitro and In Vivo Activity, Tolerability and Mechanism of Action of BX795 as an Antiviral against Herpes Simplex Virus-2 Genital Infection. Antimicrobial Agents and Chemotherapy. PMID 32601167 DOI: 10.1128/Aac.00245-20 |
0.585 |
|
| 2020 |
Wu D, Koganti R, Lambe UP, Yadavalli T, Nandi SS, Shukla D. Vaccines and Therapies in Development for SARS-CoV-2 Infections. Journal of Clinical Medicine. 9. PMID 32560227 DOI: 10.3390/Jcm9061885 |
0.349 |
|
| 2020 |
Koganti R, Suryawanshi R, Shukla D. Heparanase, cell signaling, and viral infections. Cellular and Molecular Life Sciences : Cmls. PMID 32462405 DOI: 10.1007/S00018-020-03559-Y |
0.555 |
|
| 2020 |
Iqbal A, Suryawanshi R, Yadavalli T, Volety I, Shukla D. BX795 Demonstrates Potent Antiviral Benefits against Herpes Simplex Virus-1 Infection of Human Cell Lines. Antiviral Research. 104814. PMID 32380150 DOI: 10.1016/J.Antiviral.2020.104814 |
0.622 |
|
| 2020 |
Suryawanshi RK, Koujah L, Patil CD, Ames JM, Agelidis A, Yadavalli T, Patil SV, Shukla D. Bacterial pigment prodigiosin demonstrates a unique anti-herpesvirus activity that is mediated through inhibition of prosurvival signal transducers. Journal of Virology. PMID 32295926 DOI: 10.1128/Jvi.00251-20 |
0.627 |
|
| 2020 |
Agelidis A, Shukla D. Heparanase, Heparan Sulfate and Viral Infection. Advances in Experimental Medicine and Biology. 1221: 759-770. PMID 32274736 DOI: 10.1007/978-3-030-34521-1_32 |
0.669 |
|
| 2019 |
Hadigal S, Koganti R, Yadavalli T, Agelidis A, Suryawanshi R, Shukla D. Heparanase Regulated Syndecan-1 Shedding Facilitates HSV-1 Egress. Journal of Virology. PMID 31827001 DOI: 10.1128/Jvi.01672-19 |
0.614 |
|
| 2019 |
Yadavalli T, Suryawanshi R, Ali M, Iqbal A, Koganti R, Ames J, Aakalu VK, Shukla D. Prior inhibition of AKT phosphorylation by BX795 can define a safer strategy to prevent herpes simplex virus-1 infection of the eye. The Ocular Surface. PMID 31770600 DOI: 10.1016/J.Jtos.2019.11.011 |
0.529 |
|
| 2019 |
Koganti R, Yadavalli T, Shukla D. Current and Emerging Therapies for Ocular Herpes Simplex Virus Type-1 Infections. Microorganisms. 7. PMID 31658632 DOI: 10.3390/microorganisms7100429 |
0.517 |
|
| 2019 |
Yadavalli T, Ames J, Agelidis A, Suryawanshi R, Jaishankar D, Hopkins J, Thakkar N, Koujah L, Shukla D. Drug-encapsulated carbon (DECON): A novel platform for enhanced drug delivery. Science Advances. 5: eaax0780. PMID 31453334 DOI: 10.1126/Sciadv.Aax0780 |
0.394 |
|
| 2019 |
Koujah L, Shukla D, Naqvi AR. CRISPR-Cas Based Targeting of Host and Viral Genes as an Antiviral Strategy. Seminars in Cell & Developmental Biology. PMID 30953741 DOI: 10.1016/J.Semcdb.2019.04.004 |
0.505 |
|
| 2019 |
Agelidis A, Koujah L, Suryawanshi R, Yadavalli T, Mishra YK, Adelung R, Shukla D. An Intra-Vaginal Zinc Oxide Tetrapod Nanoparticles (ZOTEN) and Genital Herpesvirus Cocktail Can Provide a Novel Platform for Live Virus Vaccine. Frontiers in Immunology. 10: 500. PMID 30949169 DOI: 10.3389/Fimmu.2019.00500 |
0.544 |
|
| 2018 |
Koujah L, Suryawanshi RK, Shukla D. Pathological processes activated by herpes simplex virus-1 (HSV-1) infection in the cornea. Cellular and Molecular Life Sciences : Cmls. PMID 30327839 DOI: 10.1007/S00018-018-2938-1 |
0.643 |
|
| 2018 |
Naqvi AR, Shango J, Seal A, Shukla D, Nares S. Herpesviruses and MicroRNAs: New Pathogenesis Factors in Oral Infection and Disease? Frontiers in Immunology. 9: 2099. PMID 30319604 DOI: 10.3389/Fimmu.2018.02099 |
0.346 |
|
| 2018 |
Lobo AM, Agelidis AM, Shukla D. Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation. The Ocular Surface. PMID 30317007 DOI: 10.1016/J.Jtos.2018.10.002 |
0.602 |
|
| 2018 |
Hopkins J, Yadavalli T, Agelidis AM, Shukla D. Host Enzymes Heparanase and Cathepsin L Promote Herpes Simplex Virus-2 Release from Cells. Journal of Virology. PMID 30232188 DOI: 10.1128/Jvi.01179-18 |
0.621 |
|
| 2018 |
Valyi-Nagy T, Fredericks B, Ravindra A, Hopkins J, Shukla D, Valyi-Nagy K. Herpes simplex virus type 1 infection promotes the growth of a subpopulation of tumor cells in 3D uveal melanoma cultures. Journal of Virology. PMID 30045986 DOI: 10.1128/Jvi.00700-18 |
0.507 |
|
| 2018 |
Naqvi AR, Seal A, Shango J, Navarette MB, Martinez G, Chapa G, Hasan S, Yadavalli T, Jaishankar D, Shukla D, Nares S. Herpesvirus-encoded microRNAs detected in human gingiva alter host cell transcriptome and regulate viral infection. Biochimica Et Biophysica Acta. PMID 29550353 DOI: 10.1016/J.Bbagrm.2018.03.001 |
0.3 |
|
| 2018 |
Jaishankar D, Yakoub AM, Yadavalli T, Agelidis A, Thakkar N, Hadigal S, Ames J, Shukla D. An off-target effect of BX795 blocks herpes simplex virus type 1 infection of the eye. Science Translational Medicine. 10. PMID 29444978 DOI: 10.1126/Scitranslmed.Aan5861 |
0.594 |
|
| 2017 |
Yadavalli T, Agelidis A, Jaishankar D, Mangano K, Thakkar N, Penmetcha K, Shukla D. Targeting Herpes Simplex Virus-1 gD by a DNA Aptamer Can Be an Effective New Strategy to Curb Viral Infection. Molecular Therapy. Nucleic Acids. 9: 365-378. PMID 29246315 DOI: 10.1016/J.Omtn.2017.10.009 |
0.591 |
|
| 2017 |
Thakkar N, Yadavalli T, Jaishankar D, Shukla D. Emerging Roles of Heparanase in Viral Pathogenesis. Pathogens (Basel, Switzerland). 6. PMID 28927006 DOI: 10.3390/Pathogens6030043 |
0.638 |
|
| 2017 |
Agelidis AM, Hadigal SR, Jaishankar D, Shukla D. Viral Activation of Heparanase Drives Pathogenesis of Herpes Simplex Virus-1. Cell Reports. 20: 439-450. PMID 28700944 DOI: 10.1016/J.Celrep.2017.06.041 |
0.643 |
|
| 2017 |
Shah D, Ali M, Shukla D, Jain S, Aakalu VK. Effects of histatin-1 peptide on human corneal epithelial cells. Plos One. 12: e0178030. PMID 28542418 DOI: 10.1371/Journal.Pone.0178030 |
0.332 |
|
| 2017 |
Duggal N, Jaishankar D, Yadavalli T, Hadigal S, Mishra YK, Adelung R, Shukla D. Zinc oxide tetrapods inhibit herpes simplex virus infection of cultured corneas. Molecular Vision. 23: 26-38. PMID 28275313 |
0.482 |
|
| 2017 |
Thakkar N, Jaishankar D, Agelidis A, Yadavalli T, Mangano K, Patel S, Tekin SZ, Shukla D. Cultured corneas show dendritic spread and restrict herpes simplex virus infection that is not observed with cultured corneal cells. Scientific Reports. 7: 42559. PMID 28198435 DOI: 10.1038/Srep42559 |
0.639 |
|
| 2016 |
Jaishankar D, Shukla D. Genital Herpes: Insights into Sexually Transmitted Infectious Disease. Microbial Cell (Graz, Austria). 3: 438-450. PMID 28357380 DOI: 10.15698/Mic2016.09.528 |
0.576 |
|
| 2016 |
Yadavalli T, Shukla D. Role of Metal and Metal Oxide Nanoparticles as Diagnostic and Therapeutic Tools for Highly Prevalent Viral Infections. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 27575283 DOI: 10.1016/J.Nano.2016.08.016 |
0.465 |
|
| 2016 |
Burnham LA, Jaishankar D, Thompson JM, Jones KS, Shukla D, Tiwari V. Liposome-Mediated Herpes Simplex Virus Uptake Is Glycoprotein-D Receptor-Independent but Requires Heparan Sulfate. Frontiers in Microbiology. 7: 973. PMID 27446014 DOI: 10.3389/Fmicb.2016.00973 |
0.601 |
|
| 2016 |
Antoine TE, Hadigal SR, Yakoub AM, Mishra YK, Bhattacharya P, Haddad C, Valyi-Nagy T, Adelung R, Prabhakar BS, Shukla D. Intravaginal Zinc Oxide Tetrapod Nanoparticles as Novel Immunoprotective Agents against Genital Herpes. Journal of Immunology (Baltimore, Md. : 1950). PMID 27183601 DOI: 10.4049/Jimmunol.1502373 |
0.5 |
|
| 2016 |
Chang K, Baginski J, Hassan SF, Volin M, Shukla D, Tiwari V. Filopodia and Viruses: An Analysis of Membrane Processes in Entry Mechanisms. Frontiers in Microbiology. 7: 300. PMID 27014223 DOI: 10.3389/Fmicb.2016.00300 |
0.623 |
|
| 2016 |
Jaishankar D, Buhrman JS, Valyi-Nagy T, Gemeinhart RA, Shukla D. Extended Release of an Anti-Heparan Sulfate Peptide From a Contact Lens Suppresses Corneal Herpes Simplex Virus-1 Infection. Investigative Ophthalmology & Visual Science. 57: 169-80. PMID 26780322 DOI: 10.1167/Iovs.15-18365 |
0.525 |
|
| 2015 |
Agelidis AM, Shukla D. Cell entry mechanisms of HSV: what we have learned in recent years. Future Virology. 10: 1145-1154. PMID 27066105 DOI: 10.2217/Fvl.15.85 |
0.573 |
|
| 2015 |
Yakoub AM, Shukla D. Basal Autophagy Is Required for Herpes simplex Virus-2 Infection. Scientific Reports. 5: 12985. PMID 26248741 DOI: 10.1038/Srep12985 |
0.602 |
|
| 2015 |
Hadigal SR, Agelidis AM, Karasneh GA, Antoine TE, Yakoub AM, Ramani VC, Djalilian AR, Sanderson RD, Shukla D. Heparanase is a host enzyme required for herpes simplex virus-1 release from cells. Nature Communications. 6: 6985. PMID 25912399 DOI: 10.1038/Ncomms7985 |
0.821 |
|
| 2015 |
Yakoub AM, Shukla D. Herpes Simplex Virus-1 Fine-Tunes Host's Autophagic Response to Infection: A Comprehensive Analysis in Productive Infection Models. Plos One. 10: e0124646. PMID 25894397 DOI: 10.1371/Journal.Pone.0124646 |
0.622 |
|
| 2015 |
Yakoub AM, Shukla D. Autophagy stimulation abrogates herpes simplex virus-1 infection. Scientific Reports. 5: 9730. PMID 25856282 DOI: 10.1038/Srep09730 |
0.634 |
|
| 2015 |
Baldwin J, Maus E, Zanotti B, Volin MV, Tandon R, Shukla D, Tiwari V. A role for 3-O-sulfated heparan sulfate in promoting human cytomegalovirus infection in human iris cells. Journal of Virology. 89: 5185-92. PMID 25717110 DOI: 10.1128/Jvi.00109-15 |
0.525 |
|
| 2015 |
Tiwari V, Tarbutton MS, Shukla D. Diversity of heparan sulfate and HSV entry: basic understanding and treatment strategies. Molecules (Basel, Switzerland). 20: 2707-27. PMID 25665065 DOI: 10.3390/Molecules20022707 |
0.568 |
|
| 2015 |
Park PJ, Chang M, Garg N, Zhu J, Chang JH, Shukla D. Corneal lymphangiogenesis in herpetic stromal keratitis. Survey of Ophthalmology. 60: 60-71. PMID 25444520 DOI: 10.1016/J.Survophthal.2014.06.001 |
0.454 |
|
| 2015 |
Jaishankar D, Yakoub AM, Bogdanov A, Valyi-Nagy T, Shukla D. Characterization of a proteolytically stable D-peptide that suppresses herpes simplex virus 1 infection: implications for the development of entry-based antiviral therapy. Journal of Virology. 89: 1932-8. PMID 25428865 DOI: 10.1128/Jvi.02979-14 |
0.578 |
|
| 2015 |
Yakoub AM, Shukla D. Analysis of Autophagy in HSV-1 Infection of Fibroblast Cells. Plos One. DOI: 10.1371/Journal.Pone.0124646.G002 |
0.576 |
|
| 2015 |
Yakoub AM, Shukla D. Analysis of Autophagy in HSV-1 Infection of HeLa Cells. Plos One. DOI: 10.1371/Journal.Pone.0124646.G001 |
0.57 |
|
| 2015 |
Baldwin J, Maus E, Zanotti B, Volin MV, Tandon R, Shukla D, Tiwari V. A role for 3-O-sulfated heparan sulfate in promoting human cytomegalovirus infection in human iris cells Journal of Virology. 89: 5185-5192. DOI: 10.1128/JVI.00109-15 |
0.34 |
|
| 2014 |
Yakoub AM, Rawal N, Maus E, Baldwin J, Shukla D, Tiwari V. Comprehensive analysis of herpes simplex virus 1 (HSV-1) entry mediated by zebrafish 3-O-Sulfotransferase isoforms: implications for the development of a zebrafish model of HSV-1 infection. Journal of Virology. 88: 12915-22. PMID 25142596 DOI: 10.1128/Jvi.02071-14 |
0.512 |
|
| 2014 |
Antoine TE, Yakoub A, Maus E, Shukla D, Tiwari V. Zebrafish 3-O-sulfotransferase-4 generated heparan sulfate mediates HSV-1 entry and spread. Plos One. 9: e87302. PMID 24498308 DOI: 10.1371/Journal.Pone.0087302 |
0.514 |
|
| 2014 |
Antoine TE, Jones KS, Dale RM, Shukla D, Tiwari V. Zebrafish: modeling for herpes simplex virus infections. Zebrafish. 11: 17-25. PMID 24266790 DOI: 10.1089/Zeb.2013.0920 |
0.603 |
|
| 2014 |
Antoine TE, Shukla D. Inhibition of myosin light chain kinase can be targeted for the development of new therapies against herpes simplex virus type-1 infection. Antiviral Therapy. 19: 15-29. PMID 23813409 DOI: 10.3851/Imp2661 |
0.546 |
|
| 2013 |
Park PJ, Antoine TE, Farooq AV, Valyi-Nagy T, Shukla D. An investigative peptide-acyclovir combination to control herpes simplex virus type 1 ocular infection. Investigative Ophthalmology & Visual Science. 54: 6373-81. PMID 23989188 DOI: 10.1167/Iovs.13-12832 |
0.55 |
|
| 2013 |
Hadigal S, Shukla D. Exploiting herpes simplex virus entry for novel therapeutics. Viruses. 5: 1447-65. PMID 23752649 DOI: 10.3390/V5061447 |
0.676 |
|
| 2013 |
Choudhary S, Burnham L, Thompson JM, Shukla D, Tiwari V. Role of Filopodia in HSV-1 Entry into Zebrafish 3-O-Sulfotransferase-3-Expressing Cells. The Open Virology Journal. 7: 41-8. PMID 23667409 DOI: 10.2174/1874357901307010041 |
0.554 |
|
| 2013 |
Coleman JL, Shukla D. Recent advances in vaccine development for herpes simplex virus types I and II. Human Vaccines & Immunotherapeutics. 9: 729-35. PMID 23442925 DOI: 10.4161/Hv.23289 |
0.429 |
|
| 2013 |
Antoine TE, Park PJ, Shukla D. Glycoprotein targeted therapeutics: a new era of anti-herpes simplex virus-1 therapeutics. Reviews in Medical Virology. 23: 194-208. PMID 23440920 DOI: 10.1002/Rmv.1740 |
0.653 |
|
| 2013 |
Baldwin J, Antoine TE, Shukla D, Tiwari V. Zebrafish encoded 3-O-sulfotransferase-2 generated heparan sulfate serves as a receptor during HSV-1 entry and spread. Biochemical and Biophysical Research Communications. 432: 672-6. PMID 23416072 DOI: 10.1016/J.Bbrc.2013.02.020 |
0.543 |
|
| 2013 |
Park PJ, Shukla D. Role of heparan sulfate in ocular diseases. Experimental Eye Research. 110: 1-9. PMID 23410824 DOI: 10.1016/J.Exer.2013.01.015 |
0.314 |
|
| 2013 |
Baldwin J, Shukla D, Tiwari V. Members of 3-O-Sulfotransferases (3-OST) Family: A Valuable Tool from Zebrafish to Humans for Understanding Herpes Simplex Virus Entry. The Open Virology Journal. 7: 5-11. PMID 23358893 DOI: 10.2174/1874357901307010005 |
0.621 |
|
| 2013 |
Baldwin J, Park PJ, Zanotti B, Maus E, Volin MV, Shukla D, Tiwari V. Susceptibility of human iris stromal cells to herpes simplex virus 1 entry. Journal of Virology. 87: 4091-6. PMID 23345512 DOI: 10.1128/Jvi.03235-12 |
0.614 |
|
| 2012 |
Trigilio J, Antoine TE, Paulowicz I, Mishra YK, Adelung R, Shukla D. Tin oxide nanowires suppress herpes simplex virus-1 entry and cell-to-cell membrane fusion. Plos One. 7: e48147. PMID 23110193 DOI: 10.1371/Journal.Pone.0048147 |
0.62 |
|
| 2012 |
Antoine TE, Mishra YK, Trigilio J, Tiwari V, Adelung R, Shukla D. Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection. Antiviral Research. 96: 363-75. PMID 23047013 DOI: 10.1016/J.Antiviral.2012.09.020 |
0.66 |
|
| 2012 |
Hubbard S, Choudhary S, Maus E, Shukla D, Swenson S, Markland FS, Tiwari V. Contortrostatin, a homodimeric disintegrin isolated from snake venom inhibits herpes simplex virus entry and cell fusion. Antiviral Therapy. 17: 1319-26. PMID 22875654 DOI: 10.3851/Imp2291 |
0.512 |
|
| 2012 |
Tiwari V, Maus E, Sigar IM, Ramsey KH, Shukla D. Role of heparan sulfate in sexually transmitted infections. Glycobiology. 22: 1402-12. PMID 22773448 DOI: 10.1093/Glycob/Cws106 |
0.574 |
|
| 2012 |
Farooq AV, Shukla D. Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Survey of Ophthalmology. 57: 448-62. PMID 22542912 DOI: 10.1016/J.Survophthal.2012.01.005 |
0.433 |
|
| 2012 |
Ali MM, Karasneh GA, Jarding MJ, Tiwari V, Shukla D. A 3-O-sulfated heparan sulfate binding peptide preferentially targets herpes simplex virus 2-infected cells. Journal of Virology. 86: 6434-43. PMID 22491462 DOI: 10.1128/Jvi.00433-12 |
0.813 |
|
| 2012 |
Tiwari V, Shukla D. Nonprofessional phagocytosis can facilitate herpesvirus entry into ocular cells. Clinical & Developmental Immunology. 2012: 651691. PMID 22481969 DOI: 10.1155/2012/651691 |
0.576 |
|
| 2012 |
Salameh S, Sheth U, Shukla D. Early events in herpes simplex virus lifecycle with implications for an infection of lifetime. The Open Virology Journal. 6: 1-6. PMID 22291864 DOI: 10.2174/1874357901206010001 |
0.665 |
|
| 2012 |
Shukla D. Unraveling the cell entry mechanisms of HSV: therapeutic potential? Future Virology. 7: 427-430. DOI: 10.2217/Fvl.12.33 |
0.457 |
|
| 2011 |
Karasneh GA, Shukla D. Herpes simplex virus infects most cell types in vitro: clues to its success. Virology Journal. 8: 481. PMID 22029482 DOI: 10.1186/1743-422X-8-481 |
0.831 |
|
| 2011 |
Karasneh GA, Ali M, Shukla D. An important role for syndecan-1 in herpes simplex virus type-1 induced cell-to-cell fusion and virus spread. Plos One. 6: e25252. PMID 21957484 DOI: 10.1371/Journal.Pone.0025252 |
0.825 |
|
| 2011 |
Mishra YK, Adelung R, Röhl C, Shukla D, Spors F, Tiwari V. Virostatic potential of micro-nano filopodia-like ZnO structures against herpes simplex virus-1. Antiviral Research. 92: 305-12. PMID 21893101 DOI: 10.1016/J.Antiviral.2011.08.017 |
0.587 |
|
| 2011 |
Tiwari V, Liu J, Valyi-Nagy T, Shukla D. Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo. The Journal of Biological Chemistry. 286: 25406-15. PMID 21596749 DOI: 10.1074/Jbc.M110.201103 |
0.47 |
|
| 2011 |
Farooq AV, Shukla D. Corneal latency and transmission of herpes simplex virus-1. Future Virology. 6: 101-108. PMID 21436960 DOI: 10.2217/Fvl.10.74 |
0.451 |
|
| 2011 |
Dosa S, Castellanos K, Bacsa S, Gagyi E, Kovacs SK, Valyi-Nagy K, Shukla D, Dermody TS, Valyi-Nagy T. Chronic progressive deficits in neuron size, density and number in the trigeminal ganglia of mice latently infected with herpes simplex virus. Brain Pathology (Zurich, Switzerland). 21: 583-93. PMID 21371157 DOI: 10.1111/J.1750-3639.2011.00485.X |
0.473 |
|
| 2011 |
Bacsa S, Karasneh G, Dosa S, Liu J, Valyi-Nagy T, Shukla D. Syndecan-1 and syndecan-2 play key roles in herpes simplex virus type-1 infection. The Journal of General Virology. 92: 733-43. PMID 21148276 DOI: 10.1099/Vir.0.027052-0 |
0.826 |
|
| 2010 |
Shah A, Farooq AV, Tiwari V, Kim MJ, Shukla D. HSV-1 infection of human corneal epithelial cells: receptor-mediated entry and trends of re-infection. Molecular Vision. 16: 2476-86. PMID 21139972 |
0.528 |
|
| 2010 |
Tiwari V, Shukla D. Phosphoinositide 3 kinase signalling may affect multiple steps during herpes simplex virus type-1 entry. The Journal of General Virology. 91: 3002-9. PMID 20810749 DOI: 10.1099/Vir.0.024166-0 |
0.538 |
|
| 2010 |
Farooq AV, Valyi-Nagy T, Shukla D. Mediators and mechanisms of herpes simplex virus entry into ocular cells. Current Eye Research. 35: 445-50. PMID 20465436 DOI: 10.3109/02713681003734841 |
0.595 |
|
| 2010 |
Tiwari V, Darmani NA, Yue BY, Shukla D. In vitro antiviral activity of neem (Azardirachta indica L.) bark extract against herpes simplex virus type-1 infection. Phytotherapy Research : Ptr. 24: 1132-40. PMID 20041417 DOI: 10.1002/Ptr.3085 |
0.613 |
|
| 2010 |
O'Donnell CD, Kovacs M, Akhtar J, Valyi-Nagy T, Shukla D. Expanding the role of 3-O sulfated heparan sulfate in herpes simplex virus type-1 entry. Virology. 397: 389-98. PMID 20004926 DOI: 10.1016/J.Virol.2009.11.011 |
0.544 |
|
| 2010 |
Oh MJ, Akhtar J, Desai P, Shukla D. A role for heparan sulfate in viral surfing. Biochemical and Biophysical Research Communications. 391: 176-81. PMID 19909728 DOI: 10.1016/J.Bbrc.2009.11.027 |
0.579 |
|
| 2010 |
Valyi-Nagy K, Dosa S, Kovacs SK, Bacsa S, Voros A, Shukla D, Folberg R, Valyi-Nagy T. Identification of virus resistant tumor cell subpopulations in three-dimensional uveal melanoma cultures. Cancer Gene Therapy. 17: 223-34. PMID 19893596 DOI: 10.1038/Cgt.2009.73 |
0.465 |
|
| 2010 |
Farooq AV, Shah A, Shukla D. The role of herpesviruses in ocular infections Virus Adaptation and Treatment. 2: 115-123. DOI: 10.2147/Vaat.S9500 |
0.599 |
|
| 2009 |
Kovacs SK, Tiwari V, Prandovszky E, Dosa S, Bacsa S, Valyi-Nagy K, Shukla D, Valyi-Nagy T. Expression of herpes virus entry mediator (HVEM) in the cornea and trigeminal ganglia of normal and HSV-1 infected mice. Current Eye Research. 34: 896-904. PMID 19895317 DOI: 10.3109/02713680903184250 |
0.562 |
|
| 2009 |
Shukla D. Viral entry mechanisms: simplicity drives complexity. The Febs Journal. 276: 7205. PMID 19878309 DOI: 10.1111/J.1742-4658.2009.07399.X |
0.568 |
|
| 2009 |
Akhtar J, Shukla D. Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. The Febs Journal. 276: 7228-36. PMID 19878306 DOI: 10.1111/J.1742-4658.2009.07402.X |
0.668 |
|
| 2009 |
Tiwari V, Darmani NA, Thrush GR, Shukla D. An unusual dependence of human herpesvirus-8 glycoproteins-induced cell-to-cell fusion on heparan sulfate. Biochemical and Biophysical Research Communications. 390: 382-7. PMID 19747451 DOI: 10.1016/J.Bbrc.2009.08.174 |
0.477 |
|
| 2009 |
O'Donnell CD, Shukla D. A novel function of heparan sulfate in the regulation of cell-cell fusion. The Journal of Biological Chemistry. 284: 29654-65. PMID 19726670 DOI: 10.1074/Jbc.M109.037960 |
0.499 |
|
| 2009 |
Tiwari V, Shukla SY, Shukla D. A sugar binding protein cyanovirin-N blocks herpes simplex virus type-1 entry and cell fusion. Antiviral Research. 84: 67-75. PMID 19665490 DOI: 10.1016/J.Antiviral.2009.07.014 |
0.545 |
|
| 2009 |
Shukla SY, Singh YK, Shukla D. Role of nectin-1, HVEM, and PILR-alpha in HSV-2 entry into human retinal pigment epithelial cells. Investigative Ophthalmology & Visual Science. 50: 2878-87. PMID 19234349 DOI: 10.1167/Iovs.08-2981 |
0.532 |
|
| 2008 |
O'Donnell CD, Shukla D. The Importance of Heparan Sulfate in Herpesvirus Infection. Virologica Sinica. 23: 383-393. PMID 19956628 DOI: 10.1007/S12250-008-2992-1 |
0.632 |
|
| 2008 |
Naithani R, Huma LC, Holland LE, Shukla D, McCormick DL, Mehta RG, Moriarty RM. Antiviral activity of phytochemicals: a comprehensive review. Mini Reviews in Medicinal Chemistry. 8: 1106-33. PMID 18855727 DOI: 10.2174/138955708785909943 |
0.379 |
|
| 2008 |
Tiwari V, Oh MJ, Kovacs M, Shukla SY, Valyi-Nagy T, Shukla D. Role for nectin-1 in herpes simplex virus 1 entry and spread in human retinal pigment epithelial cells. The Febs Journal. 275: 5272-85. PMID 18803666 DOI: 10.1111/J.1742-4658.2008.06655.X |
0.62 |
|
| 2008 |
Dixit R, Tiwari V, Shukla D. Herpes simplex virus type 1 induces filopodia in differentiated P19 neural cells to facilitate viral spread. Neuroscience Letters. 440: 113-8. PMID 18554796 DOI: 10.1016/J.Neulet.2008.05.031 |
0.621 |
|
| 2008 |
Akhtar J, Tiwari V, Oh MJ, Kovacs M, Jani A, Kovacs SK, Valyi-Nagy T, Shukla D. HVEM and nectin-1 are the major mediators of herpes simplex virus 1 (HSV-1) entry into human conjunctival epithelium. Investigative Ophthalmology & Visual Science. 49: 4026-35. PMID 18502984 DOI: 10.1167/Iovs.08-1807 |
0.631 |
|
| 2008 |
Copeland R, Balasubramaniam A, Tiwari V, Zhang F, Bridges A, Linhardt RJ, Shukla D, Liu J. Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1. Biochemistry. 47: 5774-83. PMID 18457417 DOI: 10.1021/Bi800205T |
0.532 |
|
| 2008 |
Prandovszky E, Horváth S, Gellért L, Kovács SK, Janka Z, Toldi J, Shukla D, Vályi-Nagy T. Nectin-1 (HveC) is expressed at high levels in neural subtypes that regulate radial migration of cortical and cerebellar neurons of the developing human and murine brain. Journal of Neurovirology. 14: 164-72. PMID 18444088 DOI: 10.1080/13550280801898672 |
0.39 |
|
| 2007 |
Kavouras JH, Prandovszky E, Valyi-Nagy K, Kovacs SK, Tiwari V, Kovacs M, Shukla D, Valyi-Nagy T. Herpes simplex virus type 1 infection induces oxidative stress and the release of bioactive lipid peroxidation by-products in mouse P19N neural cell cultures. Journal of Neurovirology. 13: 416-25. PMID 17994426 DOI: 10.1080/13550280701460573 |
0.552 |
|
| 2007 |
Tiwari V, ten Dam GB, Yue BY, van Kuppevelt TH, Shukla D. Role of 3-O-sulfated heparan sulfate in virus-induced polykaryocyte formation. Febs Letters. 581: 4468-72. PMID 17765228 DOI: 10.1016/J.Febslet.2007.08.029 |
0.527 |
|
| 2007 |
Tiwari V, Shukla SY, Yue BY, Shukla D. Herpes simplex virus type 2 entry into cultured human corneal fibroblasts is mediated by herpesvirus entry mediator. The Journal of General Virology. 88: 2106-10. PMID 17622611 DOI: 10.1099/Vir.0.82830-0 |
0.629 |
|
| 2007 |
Raghuraman A, Tiwari V, Zhao Q, Shukla D, Debnath AK, Desai UR. Viral inhibition studies on sulfated lignin, a chemically modified biopolymer and a potential mimic of heparan sulfate. Biomacromolecules. 8: 1759-63. PMID 17439173 DOI: 10.1021/Bm0701651 |
0.352 |
|
| 2007 |
Tiwari V, O'donnell C, Copeland RJ, Scarlett T, Liu J, Shukla D. Soluble 3-O-sulfated heparan sulfate can trigger herpes simplex virus type 1 entry into resistant Chinese hamster ovary (CHO-K1) cells. The Journal of General Virology. 88: 1075-9. PMID 17374750 DOI: 10.1099/Vir.0.82476-0 |
0.567 |
|
| 2006 |
Clement C, Tiwari V, Scanlan PM, Valyi-Nagy T, Yue BY, Shukla D. A novel role for phagocytosis-like uptake in herpes simplex virus entry. The Journal of Cell Biology. 174: 1009-21. PMID 17000878 DOI: 10.1083/Jcb.200509155 |
0.616 |
|
| 2006 |
Tiwari V, Clement C, Xu D, Valyi-Nagy T, Yue BY, Liu J, Shukla D. Role for 3-O-sulfated heparan sulfate as the receptor for herpes simplex virus type 1 entry into primary human corneal fibroblasts. Journal of Virology. 80: 8970-80. PMID 16940509 DOI: 10.1128/Jvi.00296-06 |
0.609 |
|
| 2006 |
Shukla D, Scanlan PM, Tiwari V, Sheth V, Clement C, Guzman-Hartman G, Dermody TS, Valyi-Nagy T. Expression of nectin-1 in normal and herpes simplex virus type 1-infected murine brain. Applied Immunohistochemistry & Molecular Morphology : Aimm / Official Publication of the Society For Applied Immunohistochemistry. 14: 341-7. PMID 16932027 DOI: 10.1097/00129039-200609000-00014 |
0.499 |
|
| 2006 |
O'Donnell CD, Tiwari V, Oh MJ, Shukla D. A role for heparan sulfate 3-O-sulfotransferase isoform 2 in herpes simplex virus type 1 entry and spread. Virology. 346: 452-459. PMID 16336986 DOI: 10.1016/J.Virol.2005.11.003 |
0.566 |
|
| 2005 |
Tiwari V, O'Donnell CD, Oh MJ, Valyi-Nagy T, Shukla D. A role for 3-O-sulfotransferase isoform-4 in assisting HSV-1 entry and spread. Biochemical and Biophysical Research Communications. 338: 930-7. PMID 16259945 DOI: 10.1016/J.Bbrc.2005.10.056 |
0.542 |
|
| 2005 |
Tiwari V, Clement C, Scanlan PM, Kowlessur D, Yue BY, Shukla D. A role for herpesvirus entry mediator as the receptor for herpes simplex virus 1 entry into primary human trabecular meshwork cells. Journal of Virology. 79: 13173-9. PMID 16189018 DOI: 10.1128/Jvi.79.20.13173-13179.2005 |
0.624 |
|
| 2005 |
Raghuraman A, Tiwari V, Thakkar JN, Gunnarsson GT, Shukla D, Hindle M, Desai UR. Structural characterization of a serendipitously discovered bioactive macromolecule, lignin sulfate. Biomacromolecules. 6: 2822-32. PMID 16153124 DOI: 10.1021/Bm0503064 |
0.402 |
|
| 2005 |
Scanlan PM, Tiwari V, Bommireddy S, Shukla D. Spinoculation of heparan sulfate deficient cells enhances HSV-1 entry, but does not abolish the need for essential glycoproteins in viral fusion. Journal of Virological Methods. 128: 104-12. PMID 15908019 DOI: 10.1016/J.Jviromet.2005.04.008 |
0.569 |
|
| 2005 |
Xu D, Tiwari V, Xia G, Clement C, Shukla D, Liu J. Characterization of heparan sulphate 3-O-sulphotransferase isoform 6 and its role in assisting the entry of herpes simplex virus type 1. The Biochemical Journal. 385: 451-9. PMID 15303968 DOI: 10.1042/Bj20040908 |
0.43 |
|
| 2004 |
Valyi-Nagy T, Sheth V, Clement C, Tiwari V, Scanlan P, Kavouras JH, Leach L, Guzman-Hartman G, Dermody TS, Shukla D. Herpes simplex virus entry receptor nectin-1 is widely expressed in the murine eye. Current Eye Research. 29: 303-9. PMID 15590476 DOI: 10.1080/02713680490516756 |
0.514 |
|
| 2004 |
Tiwari V, Clement C, Duncan MB, Chen J, Liu J, Shukla D. A role for 3-O-sulfated heparan sulfate in cell fusion induced by herpes simplex virus type 1. The Journal of General Virology. 85: 805-9. PMID 15039523 DOI: 10.1099/Vir.0.19641-0 |
0.584 |
|
| 2003 |
Yoon M, Zago A, Shukla D, Spear PG. Mutations in the N termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, nectin-2, and 3-O-sulfated heparan sulfate but not with nectin-1. Journal of Virology. 77: 9221-31. PMID 12915538 DOI: 10.1128/Jvi.77.17.9221-9231.2003 |
0.523 |
|
| 2003 |
Scanlan PM, Tiwari V, Bommireddy S, Shukla D. Cellular expression of gH confers resistance to herpes simplex virus type-1 entry. Virology. 312: 14-24. PMID 12890617 DOI: 10.1016/S0042-6822(03)00176-4 |
0.503 |
|
| 2002 |
Xia G, Chen J, Tiwari V, Ju W, Li JP, Malmstrom A, Shukla D, Liu J. Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1. The Journal of Biological Chemistry. 277: 37912-9. PMID 12138164 DOI: 10.1074/Jbc.M204209200 |
0.508 |
|
| 2001 |
Yabe T, Shukla D, Spear PG, Rosenberg RD, Seeberger PH, Shworak NW. Portable sulphotransferase domain determines sequence specificity of heparan sulphate 3-O-sulphotransferases. The Biochemical Journal. 359: 235-41. PMID 11563988 DOI: 10.1042/0264-6021:3590235 |
0.326 |
|
| 2001 |
Haarr L, Shukla D, Rødahl E, Dal Canto MC, Spear PG. Transcription from the gene encoding the herpesvirus entry receptor nectin-1 (HveC) in nervous tissue of adult mouse. Virology. 287: 301-9. PMID 11531408 DOI: 10.1006/Viro.2001.1041 |
0.412 |
|
| 2001 |
Shukla D, Spear PG. Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. The Journal of Clinical Investigation. 108: 503-10. PMID 11518721 DOI: 10.1172/Jci13799 |
0.609 |
|
| 2000 |
Shukla D, Dal Canto MC, Rowe CL, Spear PG. Striking similarity of murine nectin-1alpha to human nectin-1alpha (HveC) in sequence and activity as a glycoprotein D receptor for alphaherpesvirus entry. Journal of Virology. 74: 11773-81. PMID 11090177 DOI: 10.1128/Jvi.74.24.11773-11781.2000 |
0.496 |
|
| 1999 |
Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, Esko JD, Cohen GH, Eisenberg RJ, Rosenberg RD, Spear PG. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell. 99: 13-22. PMID 10520990 DOI: 10.1016/S0092-8674(00)80058-6 |
0.537 |
|
| 1999 |
Shukla D, Rowe CL, Dong Y, Racaniello VR, Spear PG. The murine homolog (Mph) of human herpesvirus entry protein B (HveB) mediates entry of pseudorabies virus but not herpes simplex virus types 1 and 2. Journal of Virology. 73: 4493-7. PMID 10196354 DOI: 10.1128/Jvi.73.5.4493-4497.1999 |
0.558 |
|
| Show low-probability matches. |